Trial Details

COMPLETED
Basic Information
Clinical ID c1131
Identifier NCT02493712
Trial Title A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Colitis, Ulcerative
Interventions DRUG: High dose|DRUG: Low dose|DRUG: Placebo
Participant Information
Sponsor Holy Stone Healthcare Co., Ltd
City Milan
Country/Region Italy
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-01-16
Primary Completion Date 2025-07-18
Completion Date 2025-04-19